January 30, 2026
Epikast
Epikast provides technology-enabled commercial and clinic...
- Round
- Series B
- Amount raised
- $2.2M
- Lead investor
- EcoR1 Capital
- Industry
- Biopharma
- Headquarters
- New York, New York
- Employees
- 11-50
- Website
- www.epikast.com
- —
Other investors
- Kos Biotech